# Evaluation of the Effect of Wismemo on Alzheimer's Dementia Patients

> **NCT04094129** · NA · WITHDRAWN · sponsor: **GenMont Biotech Incorporation**

## Conditions studied

- Alzheimer Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Wismemo
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04094129
- **Lead sponsor:** GenMont Biotech Incorporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-01-01
- **Primary completion:** 2020-02-11
- **Final completion:** 2020-02-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Couldn't sign the contract
- **Last updated:** 2020-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04094129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04094129, "Evaluation of the Effect of Wismemo on Alzheimer's Dementia Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04094129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*